Statutory Articles

International Association for Cannabinoid Medicines

Statutory Articles as resolved at the foundation meeting on 11th March 2000, revised at the General Meetings on 16th September 2000, 25th of October 2001, 5th of October 2007, 2nd October 2009 and 18th September 2015

§ 1 Name, location and business year

The association is named International Association for Cannabinoid Medicines and is a scientific society. It is located in Cologne and is included in the association registry. Its business year is the calendar year.

§ 2 Aim of the association

1. It is an interdenominational, all-party association and is independent of other organisations.

2. The aim of the association is to advance knowledge on cannabis, cannabinoids, the endocannabinoid system, and related topics especially with regard to their therapeutic potential. The mission is achieved in particular through the following actions:

  • Support for research into cannabis products and the endocannabinoid system;
  • Promotion of exchange of information between researchers, health care practitioners, patients and the public;
  • Preparation and dissemination of reliable information on the pharmacology, toxicology and therapeutic potential of cannabis and modulators of the endocannabinoid system;
  • Monitoring and documentation of national and international developments with respect tocannabinoid therapeutics;
  • Co-operation with other organisations and associations sharing the mission and goals of the IACM

3. The association observes exclusively and directly the charitable aims as described in the section "Steuerbegünstigte Zwecke" of the German "Abgabenordnung" of 1977 in the most current version. The charitability must be applied for.

§ 3 Non-profitability and the use of Association funds

  1. It is a non-profit making association and does not primarily pursue financial aims.
  2. Association funds may only be used for the statutory aims. Members do not receive a share of the profits nor any other benefits out of the association funds in their function as members.
  3. No person may receive benefits due to expenses not primarily connected with the aims of the association or receive unrelatively high payments.

§ 4 Membership

Members of the International Association for Cannabinoid Medicines may be legal or natural persons

1. Membership is split up into regular and associate members. Regular members may include the following:

  • individuals who completed a degree in medicine or pharmacy,
  • cannabis and cannabinoid researcher with a different university degree,
  • other individuals with special knowledge on cannabis/cannabinoids,
  • students of medicine or pharmacology
  • medicinal institutions and organisations.
  • Other people or institutions are associate members.

Only regular members have the right to vote. All members of the association have the right to participate in meetings, to speak and to make proposals.

2. Application for membership of the association must be directed in writing to the Board of Directors which then decides upon membership as an regular or associate member.

3. Membership of the association will end in case of death or if the member withdraws or is expelled from the association. Withdrawal from the association must be directed in writing to the Board of Directors and may take effect at the end of each quarter.

4. If an important reason exists, the Board of Directors may decide to expel a member from the association. A member may be expelled for violating the statutory articles and the interests of the association, for infringement upon the decisions and regulations of the association or damage to the associations standing. A delay in the payment of subscription fees longer than 6 months may also result in expulsion.

§ 5 Subscription

The association is financed by membership fees and donations. The annual fees will be stipulated at the General Meeting. The payment methods will be laid down by the Board of Directors.

§ 6 Bodies of the Association

The Bodies of the Association are as follows:

  1. the General Meeting
  2. the Board of Directors
  3. the Patient Representative

§ 7 General Meeting

1. The General Meeting shall take place annually before 1st of December. All members of the association are to be officially invited by the Board of Directors at least four weeks beforehand. The agenda should accompany the invitation.

2. An exceptional General Meeting must be called for by the Board of Directors if the interests of the association require this or if at least a third of the members officially request this and provide a reason.

3. The General Meeting will settle the following issues:

  • Votes for the Board of Directors
  • Subscription rules
  • Guidelines of the association work
  • Exoneration of the Board of Directors
  • The associations business and cash reports
  • Changes to statutory articles.

4. Every duly scheduled General Meeting (normal or exceptional) is a quorum. Decisions will be reached by a basic majority as long as they do not concern statutory articles or the liquidation of the association.

5. A member may officially pass on his right to vote to a third party. A representative may only receive one authority.

6. A log must be made of the General Meeting and the decisions reached. This must be signed by the Chairman of the Meeting and the Secretary.

§ 8 Board of Directors

1. The Board of Directors consists of at least 3 and at most 10 members, including a 1st and 2nd chairperson.

2.Members of the Board of Directors must be regular members of the association.

3.The Board of Directors will be voted for at the General Meeting for a period of two years. Removal of the Board of Directors can only take place at the General Meeting with a 3/4 majority of the members present. Re-election is permitted. The Board of Directors will remain in power after the period of office until the next vote takes place.

4.Responsibilities of the Board of Directors:

  • Preparation of the statement of accounts
  • Engagement or dismissal of the employees of the association
  • Management of ongoing business
  • Accounts and administration of the association
  • Invitations to General Meetings
  • Control of the work plan and budget
  • Maintaining external contacts
  • Public work and the submission of public reports between General Meetings

5.Board of Directors meetings will take place annually. A log will be made of these meetings and can be viewed by the association members.

6.The Board of Directors constitutes a quorum if half the members are present at the meeting. Decisions will be reached by a basic majority. The Board of Directors is bound by the regulations of the General Meeting.

7.The General Meeting votes 3 members of the Board of Directors as chairpersons, as described in § 8, paragraph 1. These are managers as described in § 26 of the German "Bürgerliches Gesetzbuch" (German book of law) (Attachment 2). The individual chairpersons of the Board of Directors may represent the association.

8.In order to co-ordinate the associations work, the International Association for Cannabinoid Medicines will maintain one location as the head office and further offices as required by the association work. All correspondence in the name of the association must be signed by at least one member of the Board of Directors and the address of the head office must be on the letterhead. The right to sign any correspondence may be officially delegated by the Board of Directors.

§ 9 Patient Representative

  1. Members of the association vote for up to six Patient Representatives.
  2. Associate members who suffer from a serious illness which can be therapeutically treated by cannabis products may be voted as patient representatives.
  3. At Board of Directors meetings, the Patient Representatives have the right to speak, propose and vote.

§ 10 deleted

§ 11 Cash Audit

The associations accounts will be audited annually by two cash auditors elected at the General Meeting. They are required to provide an annual statement of accounts at the latest nine months after the end of a business year and to provide a written report at the following General Meeting.

§ 12 Changes to statutory articles

Changes to statutory articles may only occur with a 3/4 majority of the voting members present.

Changes to statutory articles are to be announced with the invitation to the General Meeting.

§ 13 Dissolution of the association

  1. The decision to dissolve the association can only be reached at an exceptional General Meeting called for this purpose and with a 2/3 majority of the voting members present.
  2. In the case of dissolution of the association or the cessation of aims that carry tax privileges, the association funds are to go to the Deutsche Aids Hilfe e.V. in Berlin (Germany). The funds are to be used exclusively for non-profit making aims. Decisions of the General Meeting concerning the future application of the funds may take effect once the Board of Directors has received approval from the Revenue office.

§ 14 Log of meetings

A log must be made of the meetings held by the association authorities. This log must be handed in to the head office within two weeks of the meeting.

§ 15 Taking effect

These statutory articles take effect with the passing of the resolution at the foundation meeting and the entry in the Association registry on 11th march 2000.

Membership fees of the International Association for Cannabinoid

Medicines

as resolved at the foundation meeting on 11th march 2000. Members of the International Association for Cannabinoid Medicines support the association work

  • by the payment of an annual fee.
  • The membership fees are as follows:
  • Legal members (associations etc.) Euro 120
  • Individual members in employment – self-evaluation but at least Euro 60
  • Unemployed members and students Euro 30
  • The fee may be reduced if an application to the Board of Directors is made.
Print Friendly, PDF & Email